Dr Graham Smith left the ICR in March 2020. His team developed molecular probes to quantitatively image therapeutic response during drug development and in clinical trials.
Dr Graham Smith used his synthetic chemistry training to develop new imaging molecules that can help quantify response to therapy. He has worked at both research institutions and hospitals, and applied his translational experience across the ICR and The Royal Marsden. He left the ICR in March 2020.